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PROFOUND SYSTEMIC 
HYPOTHERMIA INHIBITS 
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NEUROTRANSMITTER 
AMINO ACIDS IN SPINAL 
CORD ISCHEMIA 
Profound hypothermia nduced with cardiopulmonary b pass has a protective 
elect on spinal cord function during operations on the thoracoabdominal 
aorta. The mechanism of this protection remains unknown. It has been 
proposed that the release of excitatory amino acids in the extracellular space 
plays a causal role in irreversible neuronal damage. We investigated the 
changes in extracellular neurotransmitter amino acid concentrations with the 
use of in vivo microdialysis in a swine model of spinal cord ischemia. All 
animals underwent left thoracotomy and right atrium-femoral rtery cardio- 
pulmonary bypass with additional aortic arch perfusion. Lumbar laminecto- 
mies were then done and microdialysis probes were inserted stereotactically in 
the anterior horn of the second and fourth segments of the lumbar spinal cord. 
The probes were perfused with artificial cerebrospinal f uid at a rate of 2 
/xl/min and 15-minute samples were assayed by high-performance liquid 
chromatography. Group 1 animals (n = 6) underwent aortic clamping distal to 
the left subclavian artery and proximal to the renal arteries for 60 minutes at 
normothermia (37 ~ C) and group 2 animals (n = 5) were cooled to a rectal 
temperature of 20 ~ C before application of aortic clamps, maintained at this 
level during cardiopulmonary b pass until the aorta was unclamped, and then 
slowly rewarmed to 37 ~ C. Seven amino acids were studied, including two 
excitatory neurotransmitters (glutamate and aspartate) and five putative 
inhibitory neurotransmitters (glycine, ~/-aminobutyric a id, serine, adenosine, 
and taurine). Glutamate xhibited a threefold increase in extracellular con- 
centration during normothermic schemia compared with baseline values and 
remained elevated until 60 minutes after reperfusion. The increase in aspar- 
tate concentration was not significant. The extracellular concentrations of
glycine and T-aminobutyric acid also increased significantly during ischemia 
and reperfusion. Hypothermia uniformly prevented the release of amino acids 
in the extracellular space. Glutamate levels remained significantly decreased 
even after rewarming to normothermia whereas glycine levels returned to 
baseline values. These results are consistent with a role for excitatory amino 
acids in the production of ischemic spinal cord injury and suggest hat the 
mechanism of hypothermic protection may be related to decreased release of 
these amino acids in the ischemic spinal cord. (J THORAC CARDIOVASC SURG 
1995;110:27-35) 
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p rofound hypothermia has long been known to  
protect against experimentally induced cerebral 
ischemia. 1-4 It  has been recently shown that pro- 
found hypothermia induced with cardi0pulmonary 
bypass (CPB) has a protective ffect on spinal cord 
function after clamping of the thoracoabdominal 
aorta in baboons. 5 Nevertheless, the mechanism by 
which hypothermia exerts its protective effect re- 
mains unknown: 
It has been postulated that the release of excita- 
tory neurotransmitters in the extracellular space of 
the central nervous system (CNS) by ischemic cells 
may contribute substantially to neuronal cell death 
in cerebral ischemic injury.6 -9 Neurotransmitter re- 
lease has been implicated in the pathophysiologic 
process of ischemic brain injury and in the mecha- 
nism of its modification by hypothermia because the 
concentration of excitatory amino acids in dialysis 
fluid sampled from ischemic brain regions increases 
during ischemia and decreases during hypothermic 
conditions. Decreased temperature inhibits the bio- 
synthesis, release, and uptake of various neurotrans- 
mitters in the brain and through such a mechanism 
may affect the outcome of the ischemic insult: 1~ 11 
We used microdialysis in an in vivo swine model 
of spinal cord ischemia, analogous to the situation 
encountered clinically for resection of thoracoab- 
dominal aneurysm, to measure xtracellular neuro- 
transmitter levels within the spinal cord before, 
during, and after ischemia. The hypothesis tested 
was that profound hypothermia affects the release of 
neurotransmitter amino acids in the spinal cord in 
this model. 
Material and methods 
Fifteen adult pigs weighing 30 to 35 kg were used. 
Humane care was provided in compliance with the "Prin- 
ciples of Laboratory Animal Care" formhlated by the 
National Society for Medical Research and the "Guide for 
the Care and Use of Laboratory Animals" prepared by the 
Institute of Laboratory Animal Resources and published 
by the National Institutes of Health (NIH Publication No. 
86-23, revised 1985). In addition, the study protocol was 
approved by the Washington University Animal Studies 
Committee. The animals were anesthetized with acetyl- 
promazine (L1 mg/kg) and atropine (0.5 mg/kg) adminis- 
tered intramuscularly and thiopental (2.5%) administered 
intravenously. Endotracheal intubation was done and 
general anesthesia was maintained with halothane (0.5% 
to 1%) and continuous intravenous infusion of fentanyl 
citrate (5 /~g/kg per hour). Pancuronium bromide (0.1 
mg/kg intravenously) was used as necessary for paralysis. 
Instrumentation. A peripheral venous line was inserted 
in the ear vein for administration f fluids and drugs and 
an arterial ine was placed in the right femoral artery. A 
second arterial line was placed in the right carotid artery 
nonocclusively under direct visualization and a venous 
line was inserted into the right internal jugular vein. 
Rectal and nasopharyngeal temperature probes (series 
400; Yellow Springs Instrument Co., Inc., Yellow Springs, 
Ohio) were inserted and were connected to a thermome- 
ter (model 43TD; Yellow Springs Instrument). Proximal 
and distal arterial pressures and a three-lead electrocar- 
diogram were continuously recorded. 
Surgical preparation. The animals were initially placed 
in the prone position. Lumbar laminectomies were done 
and the second and fourth lumbar spinal segments were 
exposed. After placement of the animal in the right lateral 
decubitus position with the pelvis rotated 45 degrees to 
the left, a left thoracotomy was done through the fourth 
intercostal space. The abdominal aorta was exposed 
through a separate left retroperitoneal incision. After 
systemic anticoagulation with porcine-derived heparin sul- 
fate (300 U/kg intravenous bolus) was accomplished, 
cannulation was done. A single cannula was inserted in 
the right atrium for return of venous blood to the pump 
oxygenator. Two arterial ines (one in the left femoral 
artery and one in the aortic arch) attached to separate 
roller pumps and two membrane oxygenators and filters 
were used. 
The animals were then turned to a full right lateral 
decubitus position and the microdialysis probes were 
implanted. A spinal temperature probe (model 511; Yel- 
low Springs Instrument) was inserted intrathecally and 
was connected to the thermometer. CPB was established 
at 100 ml/kg per minute with one third of total flow 
directed to the upper and two thirds to the lower part of 
the body, as previously described .5 The aorta was clamped 
immediately distal to the left subclavian artery and just 
proximal to the renal arteries for 60 minutes. The isolated 
aortic segment was vented to atmospheric pressure. 
Experimental design. The animals were randomly as- 
signed to two groups. In group 1 animals (n = 6) the rectal 
temperature was maintained at 37~ by the perfusate 
during the 60-minute interval of aortic occlusion (control 
group). The group 2 animals (n = 5) were cooled by the 
perfusate to a rectal temperature of 20 ~ C before applica- 
tion of the aortic clamps (hypothermia group). The dura- 
tion of CPB required to achieve this temperature aver- 
aged 20 + 4 minutes. Flow was gradually reduced uring 
cooling to 60 ml/kg per minute (20 ml/kg per minute 
through the upper cannula and 40 ml/kg per minute 
through the lower cannula). The rectal temperature and 
the total flow were maintained at these levels until the 
aorta was unclamped. Flow was then gradually increased 
and the animals were warmed to 37~ (rectal). The 
rewarming period averaged 38 + 7 minutes. In addition 
to the animals in these experimental groups, two animals 
were treated ideritically the same as the group 1 ani- 
mals (control sham) and two the same as the group 2 
animals (hypothermia sham) but did not undergo aortic 
clamping. All animals were maintained on CPB through- 
out the duration of the experiment with mean arterial 
pressure between 60 and 80 mm Hg. Determinations of
levels of arterial blood gases, serum potassium, and 
hematocrit were made at 15-minute intervals. A hemato- 
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Table I. Concentrations o f  amino acids in spinal cord microdialysates in micromoles per liter 
Baseline Ischemia (60 min) Reperfusion (15 min) Reperfusion (60 rain) 
p p 
Value Value 
Group Group (1 vs Group Group (1 vs Group Group 
1 2 2) 1 2 2) 1 2 
P P 
Value Value 
(1 vs Group Group (1 vs 








15 +2 13+3 NS 43-+6" 6 +3.  0.02 38-+6" 7 +2.4. 
3.5• 4.5-+2.1 NS 9• 2• 0.01 7.5• 2.6• 
28• 34_+7 NS 64+12" 15•  0.01 54• 24• 
2.4• 2.9• NS 11.5_+2" 1.2__0.4 0.04 9.5• 1.0• 
5 • 2 4 • 1 NS 9 • 2 2.5 _+ 1.0 0.04 7 + 2 2.8 + 1.0 
0.4 • 0.1 0.6 + 0.3 NS 1.8 -+ 0.6 0.16 • 0.05 0.04 0.2 • 0.1 0.17 • 0.1 
1.1• 1.1• NS 2.1-+0.5 0.6 +0.5 NS 1.4• 0.9-+0.5 
0.01 16 • 4 9 • 2* 0.04 
NS 1.5 • 0.8 1.1 • 0.3 NS 
0.03 23 • 8 36 • 6 NS 
0.001 2.5 • 0.9 0.7- 0.5 NS 
0.03 2 --- 0.3 4 • 1 NS 
NS 0.2 • 0.1 0.1 -+ 0.08 NS 
NS 1.1 -+ 0.5 0.9 -+ 0.5 NS 
Group 1, Control; group 2, hypothermia; NS, no statistical significance. 
*Comparison with baseline: p < 0.05. 
crit level of 20% was maintained with homologous blood 
transfusions. 
Spinal cord microdialysis. The spinal cord microdialy- 
sis technique used allows direct sampling of spinal cord 
interstitial f uid. 12-14 This technique involves the implan- 
tation of a hollow fiber within the spinal cord tissue and 
the perfusion of this fiber with artificial cerebrospinal fluid 
(CSF). During perfusion of the fiber, exchange of mole- 
cules occurs across the fiber membrane between the spinal 
cord interstitial f uid outside the fiber and the artificial 
CSF inside the fiber. Because the artificial CSF is amino 
acid free, amino acids enter the fiber and can be recovered 
in the perfusate. Two concentric microdialysis probes 
(CMA/10; Bioanalytical Systems. Inc., West Lafayette, 
Ind.) were implanted, one in the second and the other in 
the fourth lumbar spinal cord segment. The probes were 
placed in a micromanipulator (model 1761; Kopf, Inc., 
Tujunga, Calif.) and were lowered into the spinal cord 
tissue so that the 4 mm length of dialysis fiber rested 
primarily in the anterior horn. The probes were then 
cemented into place with carboy'late cement. Artificial 
CSF was infused through the probes throughout he 
experiment a a flow rate of 2/xl/min with a microinjection 
pump (CMA/100; Bioanalytical Systems). The CSF was 
bubbled with 95% N2/5% CO 2 to achieve apH of 7.2 and 
02 tension of 25 to 39 mm Hg. A 90-minute recovery 
period was allowed between the implantation of the 
microdialysis probes and initiation of experimental proto- 
cols (aortic damping in group 1 or initiation of cooling in 
group 2) to achieve steady-state amino acid levels. The 
dialysis samples were collected every 15 minutes with a 
microfraction collector (CMA/140; Bioanalytical Systems) 
and stored in a freezer before analysis. Six 15-minute 
samples were collected during the 90-minute period of 
recovery from implantation. The final 15-minute collec- 
tion served as the baseline sample. 
Sample processing and analysis. Dialysate samples 
were assayed for amino acids (glutamate, aspartate, gly- 
cine, 7-aminobutyric a id [GABA], serine, adenosine, and 
taurine) by the use of phenyl isothiocyanate d rivatiza- 
tion, high-performance liquid chromatography reverse 
phase separation, and ultraviolet detection at a wave- 
length of 254 nm following the method of Cohen, Bidling- 
meyer, and Tarvin. 15 Dialysate samples were derivatized 
with 30/xl of phenyl isothiocyanate, methanol, and trieth- 
ylamine (TEA) and were dried under vacuum. These 
samples were then reconstituted in solvent consisting of 
0.14 mol/L sodium acetate, 0.05% triethylamine, and 6% 
acetonitrile and were brought o pH 6.4 with glacial acetic 
acid. Samples were run in the same solvent with the 
column being washed between each sample run in 60% 
acetonitrile and 40.% water. Amino acids were quantified 
by use of area integration and comparison to amino acid 
standards. Recovery of amino acids by the dialysis probes 
varied between 30% and 40%. 
Evoked potentials. Spinal cord function was assessed 
lntraoperatively by evoked potential monitoring. Somato- 
sensory and motor evoked potentials were measured in all 
animals with a clinical evoked potential system (Nicolet 
Pathfinder; Nicolet Instruments, Madison, Wis.) as previ- 
ously described. 16 Somatosensory evoked traces were 
generated by stimulation of the sciatic nerve with a bipolar 
input electrode and impulses were recorded at the sixth 
thoracic level. Motor evoked traces were generated by 
direct cord stimulation at the sixth thoracic level and 
anterior spinal conduction was recorded at the fourth 
lumbar interspace. Recordings were obtained at baseline. 
during cooling, and after aortic clamping. 
Histologic analysis. The animals were killed at the 
conclusion of the experiment with an intravenous dose of 
saturated potassium chloride and were perfused first with 
4 L of normal saline solution to remove the blood and 
then with 1 L of a solution of formaldehyde. The spinal 
cords were carefully removed, the dura and the leptomen- 
inges were dissected away, and the spinal cords were 
immersed in formaldehyde overnight. Representative sec- 
tions of each segment of the spinal cord were stained with 
hematoxylin-eosin stain, Luxol fast blue and periodic 
acid-Schiff stains for myeline, 17' 18 and a silver stain for 
axons.19 The sections were reviewed by a neuropathologist 
who was blinded to the experimental conditions. 
Statistical analysis. The data obtained were analyzed 
with the Personal Computer Statistical Analysis Software 
package (PC SAS, Cary, N.C.). A two-way analysis of 
30 84 Rokkas et al. 
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Fig. 1. Line plot of time-course changes in microdialYsate concentrations of glutamate and glycine in two 
representative experiments. 
variance was used to test for significant differences among 
means in the same group, and a paired t test was used to 
test which means were different. A nonpaired t test was 
used to test for differences among means of groups 1 and 2. 
A p value of less than 0.05 was considered significant. All 
values are given as means plus or minus standard eviation. 
Results 
Neurotransmitter amino acid levels (Table I). 
Data obtained from the microdialysis probes im- 
planted in the fourth lumbar spinal cord segment 
are reported. There was no statistically significant 
difference between these data and the data obtained 
from the probe in the second lumbar segment. 
No statistically significant difference was found 
between the two groups with regard to baseline 
concentrations in any of the measured amino acid 
neurotransmitters. Amino acid levels were generally 
lower during ischemia in group 2 (tiypothermia) 
animals when compared with those in group 1 
(control) animals. 
Glutamate xhibited a threefold increase in extra- 
cellular concentration during normothermic iSch- 
emia compared with baseline values and progres- 
sively returned to baseline levels within 60 minutes 
after reperfusion. Hypothermia prevented the re- 
lease of glutamate in the extracellular space. Gluta- 
mate concentrations progressively decreased to ap- 
proximately 50% o f  baseline values during cooling 
and remained at these levels throughout he 60- 
minute period of ischemia. Characteristically, gluta- 
mate levels remained significantly decreased even 
after rewarming to normothermia. 
The increase in aspartate concentrations during 
normothermic schemia was not statistically signifi- 
cant. Although the decrease in the extracellular 
concentration of aspartate under hypothermic con- 
ditions did not reach statistical significance, there 
was a statistically significant difference between the, 
two groups at the end of the 60-minute ischemia 
interval. 
The extracellular concentration of glycine was 
significantly elevated during ischemia in group 1, 
animals and progressively returned to baseline levels 
within 60 minutes after reperfusion. Hypothermia 
prevented the release of glycine in the extracellular 
space during cooling and ischemia. However, in 
contrast with the pattern exhibited by glutamate, 
glycine levels returned to baseline values within 45 
minutes after reperfusion, soon after normothermia 
was achieved. The time course of glutamate and 
glycine concentrations in a representative experi- 
ment is depicted in Fig. 1. 
GABA exhibited a sixfold increase in extracellular 
concentration during normothermic schemia com- 
pared with baseline values and progressively re- 
turned to baseline levels within 60 minutes after 
reperfusion. There was a statistically significant dif- 
ference between the two groups in the extracellular 
concentration of GABA during aortic crossclamp- 
ing. Serine, adenosine, and taurine were detected in 
small amounts and the changes in concentration 
were subtle and not statistically significant. 
The control sham animals demonstrated stable 
baseline values of amino acid concentrations for at 
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least 150 minutes. The hypothermia sham animals 
(hypothermia without aortic crossclamping) exhib- 
ited time-course changes in dialysate amino acid 
levels that were indistinguishable from the changes 
observed in group 2 animals1 (hypothermia nd 
aortic crossclamping). 
Evoked potentials (Fig. 2). Group 1 (control an- 
imals lost motor and sensory evoked responses 
within 15 minutes after aortic clamping. These re- 
sponses failed to return With reperfusion. Group 2 
(hypothermia) nimals demonstrated voked poten- 
tials with increased latency during cooling and these 
remained unchanged during aortic clamping. Motor 
and sensory evoked potentials returned to normal 
after reperfusion and rewarming. 
tIistologic analysis. Definite evidence of early 
ischemic neuronal damage such as microvacuolation 
or eosinophilic neuronal necrosis was not found in 
the paraffin sections in either group 1 or group 2 
animals. Nonspecific hanges, including minor pete r 
chial hemorrhages and focal microscopic perivascu- 
lar chronic inflammatory changes, were seen in the 
spinal cords of animals in both groups, 
Discussion 
Profound systemic hypothermia induced with 
CPB is recognized as a potent means of conferring 
organ protection during cardiovascular nd neuro- 
surgical procedures. ~~ The protective ffect of 
hypothermia on ischemic neural tissue has been 
documented in experimental studies. 1-3 The mecha- 
nism by which hypothermia exerts this protective 
effect is thought o be related to a reduction in 
metabolic rate and thus in the oxygen requirements 
of neurons. 1'28 
Recently it has been demonstrated that even mild 
to moderate degrees of brain cooling are capable of 
conferring dramatic CerebroprotectionJ 1 Busto and 
associates 29 showed in rats that neuronal injury after 
global brain ischemia can be reduced by mild low- 
ering ofbrain temperature.Furthermore, c oling of 
the brain by a few degrees ubstantially improves 
the number of surviving neurons, particularly in 
the most vulnerable areas. Okada, Tanimoto, and 
Yoneda 3~ demonstrated in vitro that deep hypother- 
mia (21 ~ C) substantially prolonged the survival time 
of the neurons, during long-lasting anoxia. Other 
studies have documented evidence of improved 
functional outcome after hypothermic ischemia. 11 
The precise mechanism responsible for ischemic 
neuronal injury is not known. Experimental studies 
indicate that the amino acids glutamate and aspar- 
Control (Group 1) 
MEP SEP 
AXC 15 min 
AXC 60 min 
Reperfusion 35 nlin ~ ~ 
Hypothermia (Group 2) 
MEP SEP 
Baseline 
AXC 1 min 
20~ ~ 
Reperfusion 10 min 
26"C 
Reperfusion 30 rnin 
37~ 
Fig. 2. Representative traces of sensory and motor 
evoked responses from a group 1 (control) and group 2 
(hypothermia) nimal. MEP, Motor evoked potential; 
SEP, sensory evoked potential; AXC, aortic rossclamp- 
ing. 
tate are the most abundant excitatory transmitters in 
the mammalian CNS. 31' 32 In fact, the spinal cord 
was one of the first CNS areas in which it was 
demonstrated that amino acids such as glutamate 
depolarize neurons. 33 It is now established that 
spinal cord neurons use either glutamat e or aspar- 
tate as principal excitatory transmitters. 34 It may 
therefore be somewhat surprising that glutamate is
also a neurotoxinY' 36 Under normal circumstances, 
protective mechanisms limit neuronal glutamate ex- 
posure and prevent oxicity, but pathologic ondi- 
tions may alter the potential for neuronal exposure 
to glutamate. Glutamate-induced neuronal damage 
may contribute substantially to neuronal death in 
several neurologic diseases, including cerebral hy- 
poxia_ischemia.7, 3 -39 At least in part, the beneficial 
effect of hypothermia gainst hypoxia may be a 
result of inhibition of the biosynthesis, release, and 
uptake of various neurotransmitters. Therefore sys- 
temic hypothermia can be considered to protect 
neurons by means of the inhibition of increase in 
32 Rokkas et aL 
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intracellular f ee calcium through the reduction of 
extracellular glutamate concentration. 
In experiments involving microdialysis in rats, 
Busto and associates 1~ found that animals whose 
intraischemic brain temperature was maintained at 
36 ~ C demonstrated a sevenfold increase in extracel- 
lular glutamate concentrations when subjected to 20 
minutes of ischemia. When brain temperature was 
maintained between 30 ~ C and 33 ~ C, the release of 
glutamate was completely inhibited. There was no 
difference between the control and the experimental 
group in the degree of intraischemic local cerebral 
blood flow reduction and the tissue accumulation f 
free fatty acids. They concluded that mild hypother- 
mia does not affect he severity of the ischemic insult 
as measured by the magnitude of blood flow reduc- 
tion or energy depletion and suggested that hypo- 
thermia may exert its protective ffect by reducing 
the ischemia-induced glutamate release. Similarly, 
Mitani and Kataoka 4~ showed in gerbils that when 
brain temperature was maintained at 31 ~ C during 
ischemia, the release of glutamate attenuated to 
25% of the concentration in ischemic normothermic 
animals and there was no neuronal damage. 
In our study, the clinical situation of resection of 
the thoracoabdominal aorta was simulated in a 
swine model of spinal cord ischemia. The swine 
spinal cord has blood supply similar to that of 
human beings and has been used extensively in 
metabolic studies of the spinal cord. 41-43 In a pri- 
mate model of spinal cord ischemia similar to the 
model used in this study, we demonstrated that 
systemic profound hypothermia (15 ~ C) has a pro- 
tective effect on spinal cord function after 60 min- 
utes of aortic crossclamping. 5 In the present study, 
animals were only cooled to a systemic temperature 
of 20~ in anticipation of marked reduction in 
extracellular neurotransmitter concentrations even 
with small temperature d creases. 1~Because xcito- 
toxicity appears to be a major pathogenetic mecha- 
nism in neuronal ischemic injury, moderate systemic 
hypothermia (20 ~ to 30 ~ C) may prove to provide 
adequate neuroprotection during cardiovascular 
procedures that involve hypothermic CPB or circu- 
latory arrest for brain or spinal cord protection. 
Glutamate is thought to be the primary excitatory 
amino acid in the spinal cord and is normally found 
in considerably higher concentrations than those of 
aspartate.44, 45 In our study, the extracellular con- 
centration of glutamate xhibited a threefold in- 
crease during ischemia and progressively normal- 
ized within 60 minutes from reperfusion i  control 
(group 1) animals whereas the increase in aspartate 
levels was not statistically significant. These results 
are in agreement with the findings of Simpson, 
Robertson, and Goodman, 46who performed micro- 
dialysis in the spinal cords of rabbits ubmitted to 20 
minutes of ischemia. Brain microdialysis studies in 
rats have shown similar patterns in time-course 
changes but a much greater (6- to 15-fold) in- 
crease in the extracellular concentration of giuta- 
mate.9, lO, 12,40, 47 This difference may explain the 
higher vulnerability of the brain to ischemia when 
compared with the vulnerability of the spinal cord. 
Hypothermia prevented the release of glutamate 
in the extracellular fluid in group 2 animals. Fur- 
thermore, there was no increase in this reduced 
concentration throughout the 60-minute period of 
ischemia. In this regard, group 2 animals were 
indistinguishable from sham animals that underwent 
cooling without aortic clamping. Our finding that 
extracellular glutamate levels remain significantly 
decreased for at least 60 minutes after reperfusion 
and rewarming to normothermia may imply that 
hypothermia continues to have a protective ffect on 
neuronal function for some time after normother- 
mia is achieved. Clinically, this may provide some 
protection from ischemic spinal cord insults during 
intraoperative or immediate postoperative episodes 
of hypotension and hypoperfusion, potentially re- 
ducing the incidence of delayed paraplegia. 
Aspartate was found in low concentrations i  the 
spinal cord and the increase in extracellular concen- 
tration was not Significantly altered uring ischemia 
or reperfusion, in agreement with the findings of 
other investigators. 46 
Recent studies have established that nongluta- 
matergic neurotransmitters a e also intimately in- 
volved in ischemic neuronal injury. 48' 49 Other neu- 
rotransmitters that may play a role in modulating 
the excitotoxic effects of glutamate include glycine, 
the most abundant inhibitory neurotransmitter in 
the spinal cord, 44" 45 and GABA, another putative 
inhibitory neurotransmitter. It has been postulated 
that an imbalance between excitation and inhibition 
consequent to the release of multiple neuromodu- 
lators into the extracellular fluid during and after 
ischemia may constitute a major determinant of 
ischemic neuronal damage. 4s 49 
Glycine concentrations were the highest of any 
amino acid measured at baseline in our study. 
Previous reports have established that glycine has 
the highest concentration f all amino acids in the 
ventral gray matter, 45 whereas the same is true for 
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glutamate in the dorsal gray matter. Furthermore, 
our results show that the extracellular concentra- 
tions of glycine and GABA increased significantly 
during ischemia, and after eperfusion they followed 
a course of normalization similar to that of gluta- 
mate. These findings are consistent with previously 
reported ata from studies on the spinal cord 46 and 
the areas of the brain that are least vulnerable to 
ischemia.48, 49
Profound systemic hypothermia prevented the 
release of glycine and GABA in the extracellular 
space during cooling and ischemia in our study. 
However, in contrast o concentrations of glycine, 
extracellular concentrations of GABA remained e- 
creased long after reperfusion and rewarming. Al- 
though the measured GABA concentrations were 
generally low and this difference did not achieve 
statistical significance when postischemic concentra- 
tions were compared with baseline values, the im- 
portance of this finding is unclear at present and 
may deserve further investigation. 
The changes in other amino acids measured in 
our study were not significant in either group of 
animals. The most intriguing of these amino acids is 
taurine, which is one of the most abundant free 
amino acids in the brain: only glutamate is consis- 
tently higher in concentration. 5~ The role of taurine 
in the spinal cord is not clear but it does hot appear 
that taurine plays any significant role in modulating 
the ischemic injury. 
The functional outcome of the animals in our 
study is not known, because they were not allowed 
to survive. However, in a similar experimental prep- 
aration in baboons we showed that profound sys- 
temic hypothermia induced with CPB has a protec- 
tive effect on spinal cord function. 5 Monitoring of 
sensory and motor evoked potentials in group 1 
animals confirmed the induction of spinal cord 
ischemia in our experimental preparation, because 
the evoked responses disappeared shortly after aor- 
tic clamping, as also documented in previous tud- 
ies. 16 Group 2 animals demonstrated increased la- 
tency of evoked responses as a result of cooling but 
they never showed isoelectric potentials during cool- 
ing or aortic crossclamping. This observation is 
consistent with the results of Coles and associates, sl 
who found that spinal evoked potentials are only 
abolished at temperatures lower than 10 ~ C. Fur- 
thermore, there was no change in the amplitude or 
latency of evoked potentials during the 60-minute 
period of ischemia. In fact, the time course of these 
potentials in group 2 animals was identical to that in 
sham animals that underwent cooling for a compa- 
rable period without aortic clamping. The lack of 
histologic findings is probably related to the lack of 
time for histologic hanges to mature. 
In summary, our evidence indicates that the in- 
crease in the extracellular concentrations of excitatory 
amino acids, particularly glutamate, is consistent with 
the hypothesis that excitotoxins mediate neuronal 
damage in the ischemic spinal cord during ischemia 
produced by aortic clamping. Furthermore, we have 
shown that he protective ffect of hypothermia on the 
spinal cord during operatio n on the thoracoabdominal 
aorta is related to decreased release of neurotransmit- 
ter amino acids in the ischemic spinal cord. 
From our data, as well as from data in the 
literature, it is unclear whether the same degree of 
functional protection of the spinal cord that can be 
achieved with profound hypothermia can also be 
achieved with cooling to moderate degrees of hypo- 
thermia. Further studies to define the protective 
effect of systemic ooling to temperatures between 
20 ~ and 30~ may be warranted. Nevertheless, 
better understanding of the mechanisms involved in 
neuronal death opens new horizons in the field of 
pharmacoprotection. Pharmacologic antagonism of
glutamate receptor-mediated neurotoxicity appears 
to be an appealing concept, and it may provide a 
novel approach to amelioration of the effects of 
spinal cord ischemia. 52 , 
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